Diseases [C] » Cardiovascular Diseases [C14] » Vascular Diseases » Arterial Occlusive Diseases » Arteriosclerosis » Atherosclerosis
Description
A thickening and loss of elasticity of the walls of ARTERIES that occurs with formation of ATHEROSCLEROTIC PLAQUES within the ARTERIAL INTIMA. MeSH
Hierarchy View
Subtype Terms (1)
Peripheral Arterial Disease
178 drugs (97 approved, 81 experimental)
Phase 4 Indicated Drugs (78)
Phase 3 Indicated Drugs (48)
Phase 2 Indicated Drugs (44)
Phase 1 Indicated Drugs (22)
Other Experimental Indicated Drugs (45)
Organization Involved with Phase 4 Indications (154)
Ada and Hagbart Waages Humanitarian and Charity Foundation
Alf and Aagot Helgesens Research Foundation
American College of Clinical Pharmacy
Applied Health Research Centre
Aristotle University of Thessaloniki
Beijing Clinstech-med consulting Co., Ltd
Beijing Sino-Japan Friendship Hospital
Canadian Institutes of Health Research (CIHR)
Carl T. Hayden Medical Research Foundation
Case Western Reserve University
Centro de estudios en Cardiologia Intervencionista
CIHR Canadian HIV Trials Network
Dutch Diabetes Research Foundation
Federal University of Health Science of Porto Alegre
Federal University of Rio Grande do Sul
Hamilton Health Sciences Corporation
Helena Laboratories Point of Care
Hospital Universitario Arnau de Vilanova de Lleida
hospital universitario marques Valdecilla
Icahn School of Medicine at Mount Sinai
Los Angeles Biomedical Research Institute
National Cheng Kung University
National Defense Medical College, Japan
Pauls Stradins Clinical University Hospital
People's Liberation Army of China
Russian Cardiology Research and Production Center
State University of New York, Buffalo
Steno Diabetes Center Copenhagen
Swiss National Science Foundation
Technical University of Munich
The Norwegian Council on Cardiovascular Disease
Ukrainian Medical Stomatological Academy
University of British Columbia
Organization Involved with Phase 3 Indications (82)
Andalusian Initiative for Advanced Therapies
Andalusian Initiative in Advanced Therapies
Assistance Publique - Hôpitaux de Paris
Centers for Disease Control and Prevention (CDC)
Heart and Stroke Foundation of Canada
Institute for Atherosclerosis Research, Russia
National Center for Complementary and Integrative Health (NCCIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
National Institute of Neurological Disorders and Stroke (NINDS)
Norwegian Cardiovascular Council
Office of Dietary Supplements (ODS)
Oregon Health and Science University
Organization Involved with Phase 2 Indications (45)
HonorHealth Research Institute
Medical University of South Carolina
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Organization Involved with Phase 1 Indications (10)
Organization Involved with Other Experimental Indications (67)
Canadian Collaborative Research Network
Chicago Area Patient Centered Outcomes Research Network
Chinese University of Hong Kong
Greater Plains Collaborative Clinical Data Research Network
HealthCore-Anthem Research Network
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Intermountain Research and Medical Foundation
Mid-South Clinical Data Research Network
National Watermelon Promotion Board
New York City Clinical Data Research Network
PaTH Clinical Data Research Network
Research Action for Health Network
Satakunta Sea Buckthorn Society
Shahid Beheshti University of Medical Sciences
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
